ENLIVEX THERAPEUTICS LTD ENLV 深 沪
等待开盘 07-21 09:30:00 美东时间
1.19
-0.010
-0.83%
华盛通- 最 高1.27
- 今 开1.20
- 成交量 7.44万股
- 最 低 1.16
- 昨 收 1.20
- 总市值 2838.14万
- 52周最高 1.76
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.8101
- 委 比 -48.00%
- 总股本 2384.99万
- 历史最高 44.90
- 量 比 1.03
- 振 幅 9.17%
- 历史最低 0.8101
- 每 手 1
- 风险率 0.19%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Enlivex Therapeutics To Feature Data From Ongoing Clinical Study Evaluating Proprietary Allocetra Off-The-Shelf Macrophage Reprogramming Cell Therapy, In Patients With Knee Osteoarthritis At EULAR European Congress Of Rheumatology
Enlivex Therapeutics Ltd. (NASDAQ:ENLV, the "Company"))), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present a poster at the European Alliance of Associations for
06-10 20:34
Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology
Enlivex Therapeutics will present data on theirAllocetra™ cell therapy for knee osteoarthritis at the EULAR Congress in Barcelona. The Phase I/II trial shows promising safety and efficacy, including pain reduction and improved joint function. Enrollment for the Phase II stage is complete, with topline data expected by August 2025. Company executives will attend the conference. --- 总结：Enlivex将在巴塞罗那的EULAR大会上展示其用于膝关节骨关节炎的Allocetra™细胞疗法数据。I/II期试验显示...
06-10 12:30
国投证券-生物医药行业新药周观点：脓毒症治疗迎来新突破，远大医药STC3141中国2期成功-250518
（转自：研报虎） 本周新药行情回顾： 2025年5月12日-2025年5月16日，新药板块涨幅前5企业：君圣泰(19.78%)、德琪医药(18.34%)...
05-18 17:56
Enlivex to Present Allocetra™ Insights at OARSI 2025
Enlivex ( ($ENLV) ) has issued an update. On April 23, 2025, Enlivex Therapeuti...
04-23 20:58
美股大行评级 | 潜在涨幅117.92%！Proficient Auto Logistics获Stifel升目标价至18美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1114836103639961600.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Stifel：维持Proficient Auto Logistics(PAL)"买入"评级，目标价从17美元升至18美元</p> <p>• Craig-Hallum：上调Sportsman's Warehouse(SPWH
04-04 15:42
Enlivex Doses First Patient In Phase I Trial Evaluating Allocetra In Patients With TMJ Osteoarthritis
Temporomandibular joint (TMJ) osteoarthritis is a degenerative, debilitating and progressive disease, the second most common musculoskeletal condition affecting five to 12% of the population globallyTMJ causes pain and
04-03 20:06
Enlivex Therapeutics Releases 2024 Financial Statements
Enlivex ( ($ENLV) ) has issued an update. Enlivex Therapeutics Ltd. has release...
04-01 04:59
美股大行评级 | 潜在涨幅586.27%！HC Wainwright & Co.上调Enlivex Therapeutics目标价至7美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1111211417521721345.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Enlivex Therapeutics(ENLV)"买入"评级，目标价从6美元升至7美元</p> <p>• Maxim Group：上调Nexalin Technolo
03-25 09:37
快讯 | Enlivex Therapeutics Ltd : H.c. Wainwright 将目标价从6美元上调至7美元
Enlivex Therapeutics Ltd : H.c. Wainwright Raises Target Price to $7 From $6
03-24 18:07
Enlivex Suspends Stock Trading Amid Internal Investigation
Enlivex ( ($ENLV) ) just unveiled an announcement. Enlivex has announced the su...
02-18 14:57
